Biology of germinal centers in lymphoid tissue.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMID 8070632)

Published in FASEB J on August 01, 1994

Authors

G J Thorbecke1, A R Amin, V K Tsiagbe

Author Affiliations

1: Department of Pathology, New York University School of Medicine, New York 10016.

Articles citing this

Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med (1998) 3.01

Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc Natl Acad Sci U S A (1996) 1.71

Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing. J Exp Med (1997) 1.59

Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J Exp Med (1996) 1.55

Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest (1997) 1.52

Severe attenuation of the B cell immune response in Msh2-deficient mice. J Exp Med (1999) 1.42

Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges. AIDS (2014) 1.41

Germinal center founder cells display propensity for apoptosis before onset of somatic mutation. J Exp Med (1997) 1.21

Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway. J Exp Med (1997) 1.13

Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J Virol (1996) 1.11

Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J Exp Med (1998) 1.09

A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Am J Pathol (1995) 1.07

Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein. J Exp Med (1998) 1.04

Augmented expression of a human gene for 8-oxoguanine DNA glycosylase (MutM) in B lymphocytes of the dark zone in lymph node germinal centers. J Exp Med (1997) 0.99

Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. Am J Pathol (1996) 0.97

Scrapie-specific pathology of sheep lymphoid tissues. PLoS One (2007) 0.96

Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene. Proc Natl Acad Sci U S A (2004) 0.91

Follicular dendritic cells in health and disease. Front Immunol (2012) 0.90

A quantitative assessment of primary and secondary immune responses in cattle using a B cell ELISPOT assay. Vet Res (2008) 0.90

Changes in human lymphocyte subpopulations in tonsils and regional lymph nodes of human head and neck squamous carcinoma compared to control lymph nodes. BMC Immunol (2001) 0.88

In vivo expression of interleukin-8, and regulated on activation, normal, T-cell expressed, and secreted, by human germinal centre B lymphocytes. Immunology (2003) 0.87

Life and death within germinal centres: a double-edged sword. Immunology (2002) 0.86

The surface epithelium of recurrent infected palatine tonsils is rich in gammadelta T cells. Clin Exp Immunol (1998) 0.82

Gpr97 is essential for the follicular versus marginal zone B-lymphocyte fate decision. Cell Death Dis (2013) 0.79

An HIV-1 envelope glycoprotein trimer with an embedded IL-21 domain activates human B cells. PLoS One (2013) 0.78

A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV. PLoS One (2015) 0.77

Articles by these authors

The role of nitric oxide in inflammation and immunity. Arthritis Rheum (1998) 1.54

B cell lymphomas of C57L/J mice; the role of natural killer cells and T helper cells in lymphoma development and growth. Leuk Res (2000) 1.45

Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum (1997) 1.42

Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention. J Biol Chem (2000) 1.37

Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells. Clin Exp Metastasis (2000) 1.30

Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep (2001) 1.30

Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage (2002) 1.28

Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol (2000) 1.28

Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum (2001) 1.25

Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production. Inflamm Res (2000) 1.21

The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol (2001) 1.15

Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8. Proc Assoc Am Physicians (1998) 1.14

A role for FAK in the Concanavalin A-dependent secretion of matrix metalloproteinase-2 and -9. Oncogene (2000) 1.12

Functional genomic analysis in arthritis-affected cartilage: yin-yang regulation of inflammatory mediators by alpha 5 beta 1 and alpha V beta 3 integrins. J Immunol (2000) 1.04

TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha. J Immunol (1998) 1.03

Tetracycline up-regulates COX-2 expression and prostaglandin E2 production independent of its effect on nitric oxide. J Immunol (1999) 0.98

Regulation of cytosolic COX-2 and prostaglandin E2 production by nitric oxide in activated murine macrophages. J Immunol (1999) 0.93

A novel mechanism of action of chemically modified tetracyclines: inhibition of COX-2-mediated prostaglandin E2 production. J Immunol (1999) 0.92

Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease. Mol Oral Microbiol (2010) 0.91

"A system biology" approach to bioinformatics and functional genomics in complex human diseases: arthritis. Curr Issues Mol Biol (2002) 0.87

Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region. J Immunol (1996) 0.86

Chemically modified tetracyclines inhibit inducible nitric oxide synthase expression and nitric oxide production in cultured rat mesangial cells. Biochem Biophys Res Commun (1996) 0.85

Human T cell IgD receptors react with O-glycans on both human IgD and IgA1. Eur J Immunol (1998) 0.83

IgD receptors on murine T-helper cells bind to Fd and Fc regions of immunoglobulin D. Proc Natl Acad Sci U S A (1991) 0.82

A rapid one step purification procedure for murine IgD based on the specific affinity of Bandeiraea (Griffonia) simplicifolia-1 for N-linked carbohydrates on IgD. J Immunol Methods (1990) 0.80

Regulation of nitric oxide and prostaglandin E2 production by CSAIDS (SB203580) in murine macrophages and bovine chondrocytes stimulated with LPS. Inflamm Res (1999) 0.80

Germinal center cells are a major IL-5-responsive B cell population in peripheral lymph nodes engaged in the immune response. J Immunol (1990) 0.80

T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners. East Afr Med J (1997) 0.80

Oligomeric IgD augments and monomeric IgD inhibits the generation of IgG memory antibody responses in normal, but not in IgD-deficient, mice. J Immunol (1995) 0.79

META-controlled env-initiated transcripts encoding superantigens of murine Mtv29 and Mtv7 and their possible role in B cell lymphomagenesis. J Immunol (2001) 0.79

Proliferative response of T cells from tumor-immune chickens to carcinogen-induced fibrosarcoma cells. Int J Cancer (1990) 0.78

Evaluation of presence and functional activity of potentially self-reactive T cells in aged mice. Int Immunol (1996) 0.78

Protection against apoptosis in chicken bursa cells by phorbol ester in vitro. Cell Immunol (1993) 0.78

Metabolism of n-alkanes by Aspergillus japonicus. Folia Microbiol (Praha) (1987) 0.78

Gene therapy for chondrocytes. Clin Orthop Relat Res (2000) 0.76

Components essential for the generation of germinal centers. Dev Immunol (1998) 0.76

Up-regulation of inducible nitric oxide synthase and production of nitric oxide by the Swarm rat and human chondrosarcoma. J Orthop Res (1998) 0.75

Regulation of nitric oxide production by salicylates and tenidap in human OA-affected cartilage, rat chondrosarcomas and bovine chondrocytes. Osteoarthritis Cartilage (1998) 0.75

Structural and functional properties of mouse-human chimeric IgD. Hum Antibodies Hybridomas (1992) 0.75

The effect of choline supplementation in growing pullet and laying hen diets. Poult Sci (1982) 0.75

Superantigens related to B cell hyperplasia. Springer Semin Immunopathol (1996) 0.75

Cytokine responsiveness of germinal center B cells. Adv Exp Med Biol (1994) 0.75

Regulation of IgD-receptor expression on murine T cells. I. Characterization and metabolic requirements of the process leading to their expression. Cell Immunol (1993) 0.75

Trifluorothymidine 0.5% ointment in the treatment of aciclovir-resistant mucocutaneous herpes simplex in AIDS. AIDS (1996) 0.75

Induction of germinal centers by MMTV encoded superantigen on B cells. Dev Immunol (2001) 0.75

Catabolism of benzoate and salicylate by Aspergillus japonicus. Indian J Exp Biol (1984) 0.75